Saudi Central Bank lifted its position in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 92.0% during the second quarter, Holdings Channel reports. The institutional investor owned 33,282 shares of the real estate investment trust’s stock after purchasing an additional 15,944 shares during the period. Saudi Central Bank’s holdings in Ventas were worth $2,955,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in VTR. Dynamic Wealth Strategies LLC purchased a new stake in Ventas in the 1st quarter worth $25,000. Wiser Advisor Group LLC bought a new stake in Ventas in the third quarter worth $27,000. Silvant Capital Management LLC purchased a new position in shares of Ventas during the 2nd quarter worth about $28,000. Meeder Asset Management Inc. purchased a new position in shares of Ventas during the second quarter valued at approximately $30,000. Finally, IFC & Insurance Marketing Inc. bought a new position in Ventas in the 4th quarter valued at $30,000. Institutional investors own 94.18% of the company’s stock.
Ventas Stock Performance
Shares of Ventas stock opened at $90.27 on Tuesday. The stock has a 50 day moving average of $92.96 and a 200 day moving average of $87.86. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The firm has a market capitalization of $46.30 billion, a price-to-earnings ratio of 167.17, a PEG ratio of 3.52 and a beta of 0.70. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60.
Analyst Ratings Changes
A number of brokerages have recently commented on VTR. The Goldman Sachs Group reaffirmed a “buy” rating and set a $110.00 target price on shares of Ventas in a research report on Tuesday, May 19th. Royal Bank Of Canada raised their target price on Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Ventas in a report on Tuesday, June 16th. JPMorgan Chase & Co. lifted their price objective on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Monday, May 11th. Finally, Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, July 21st. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $99.00.
Get Our Latest Stock Analysis on Ventas
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
